Location
Ann Arbor
Posted
June 20, 2026
Commute
Local Area
Local Opportunity Near You!
This job is in your area. Enjoy a short commute and work close to home.
Job Description
RESEARCH FELLOW
Apply Now
**Job Summary**
An exciting opportunity has been created for an experienced researcher to join the Alumkal Laboratory ( https://alumkal.lab.medicine.umich.edu/ ) at the U of M Division of Heme-Onc and the Rogel Cancer Center in Ann Arbor, MI. This individual will join as a post-doctoral researcher and work directly with Dr. Joshi Alumkal, Leader of the U of M Prostate/Genitourinary Oncology Cancer Section. He/she will be an integral member of research team whose focus is epigenetics and drug resistance in prostate cancer.
Our laboratory focuses on identifying mechanisms by which key chromatin modifying enzymes and chromatin readers drive transcription of pathways that promote treatment resistance. We use genomic/epigenomic studies in prostate cancer clinical samples and prostate cancer cell line model systems and functional studies to understand this process. Our goal is to develop new, targeted treatment strategies for men ...
Apply Now
**Job Summary**
An exciting opportunity has been created for an experienced researcher to join the Alumkal Laboratory ( https://alumkal.lab.medicine.umich.edu/ ) at the U of M Division of Heme-Onc and the Rogel Cancer Center in Ann Arbor, MI. This individual will join as a post-doctoral researcher and work directly with Dr. Joshi Alumkal, Leader of the U of M Prostate/Genitourinary Oncology Cancer Section. He/she will be an integral member of research team whose focus is epigenetics and drug resistance in prostate cancer.
Our laboratory focuses on identifying mechanisms by which key chromatin modifying enzymes and chromatin readers drive transcription of pathways that promote treatment resistance. We use genomic/epigenomic studies in prostate cancer clinical samples and prostate cancer cell line model systems and functional studies to understand this process. Our goal is to develop new, targeted treatment strategies for men ...